Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Accendra Health (ACH) Current Assets (2016 - 2025)

Historic Current Assets for Accendra Health (ACH) over the last 17 years, with Q3 2025 value amounting to $2.1 billion.

  • Accendra Health's Current Assets rose 71.51% to $2.1 billion in Q3 2025 from the same period last year, while for Sep 2025 it was $2.1 billion, marking a year-over-year increase of 71.51%. This contributed to the annual value of $2.0 billion for FY2024, which is 388.88% down from last year.
  • Per Accendra Health's latest filing, its Current Assets stood at $2.1 billion for Q3 2025, which was up 71.51% from $2.3 billion recorded in Q2 2025.
  • Accendra Health's Current Assets' 5-year high stood at $2.6 billion during Q1 2022, with a 5-year trough of $2.0 billion in Q4 2024.
  • For the 5-year period, Accendra Health's Current Assets averaged around $2.3 billion, with its median value being $2.3 billion (2023).
  • In the last 5 years, Accendra Health's Current Assets skyrocketed by 2311.83% in 2021 and then crashed by 1276.24% in 2023.
  • Quarter analysis of 5 years shows Accendra Health's Current Assets stood at $2.3 billion in 2021, then dropped by 1.15% to $2.3 billion in 2022, then dropped by 8.38% to $2.1 billion in 2023, then dropped by 3.89% to $2.0 billion in 2024, then increased by 5.48% to $2.1 billion in 2025.
  • Its last three reported values are $2.1 billion in Q3 2025, $2.3 billion for Q2 2025, and $2.2 billion during Q1 2025.